Guiqing Liang

887 total citations
21 papers, 484 citations indexed

About

Guiqing Liang is a scholar working on Molecular Biology, Pharmacology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Guiqing Liang has authored 21 papers receiving a total of 484 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Pharmacology and 7 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Guiqing Liang's work include Pharmacogenetics and Drug Metabolism (8 papers), Hormonal Regulation and Hypertension (5 papers) and Cardiovascular, Neuropeptides, and Oxidative Stress Research (3 papers). Guiqing Liang is often cited by papers focused on Pharmacogenetics and Drug Metabolism (8 papers), Hormonal Regulation and Hypertension (5 papers) and Cardiovascular, Neuropeptides, and Oxidative Stress Research (3 papers). Guiqing Liang collaborates with scholars based in United States, Switzerland and China. Guiqing Liang's co-authors include Lijun Sun, Keizo Koya, Dean F. Rigel, Arco Y. Jeng, Michael E. Beil, Fumin Fu, Zhiqiang Xia, David A. James, Hao Li and Weiwen Ying and has published in prestigious journals such as Science, Molecular and Cellular Biology and Analytical Chemistry.

In The Last Decade

Guiqing Liang

19 papers receiving 473 citations

Peers

Countries citing papers authored by Guiqing Liang

Since Specialization

Citations

This map shows the geographic impact of Guiqing Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guiqing Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guiqing Liang more than expected).

Fields of papers citing papers by Guiqing Liang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guiqing Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guiqing Liang. The network helps show where Guiqing Liang may publish in the future.

Co-authorship network of co-authors of Guiqing Liang

This figure shows the co-authorship network connecting the top 25 collaborators of Guiqing Liang. A scholar is included among the top collaborators of Guiqing Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guiqing Liang. Guiqing Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Utility of Chimeric Mice with Humanized Livers for Predicting Hepatic Organic Anion-Transporting Polypeptide 1B–Mediated Clinical Drug-Drug Interactions 2024 ·Drug Metabolism and Disposition ·Bo Feng, Guiqing Liang, (unknown), Shaolan Li, Hui Huang, John S. Williams, Hong Gao, Yoshio Morikawa, Sanjeev Kumar	3
2	Percutaneous vertebroplasty in osteoporotic vertebral compression fracture with huge spinal epidural hematoma 2022 ·Medicine ·(unknown), (unknown), Guiqing Liang, (unknown)	0
3	Bone morphogenetic protein 2/7 promotes repair of bone defect via induction of endochondral ossification 2021 ·Tropical Journal of Pharmaceutical Research ·Jian Wu, (unknown), Guiqing Liang	1
4	The activities of drug inactive ingredients on biological targets 2020 ·Science ·Joshua Pottel, Duncan Armstrong, Ling Zou, Alexander Fekete, Xi‐Ping Huang, Hayarpi Torosyan, Dallas Bednarczyk, Steven Whitebread, Barun Bhhatarai, Guiqing Liang, Hong Jin, S. Nassir Ghaemi, Samuel T. Slocum, Katalin Lukács, John J. Irwin, Ellen L. Berg, Kathleen M. Giacomini, Bryan L. Roth, Brian K. Shoichet, László Urbán	63
5	Discovery of a Novel Piperidine-Based Inhibitor of Cholesteryl Ester Transfer Protein (CETP) That Retains Activity in Hypertriglyceridemic Plasma 2017 ·Journal of Medicinal Chemistry ·Ken Yamada, Margaret E. Brousseau, (unknown), (unknown), (unknown), Yuki Iwaki, Toshio Kawanami, Daniel LaSala, Guiqing Liang, Hironobu Mitani, K. Nonomura, Osamu Ohmori, Meihui Pan, Dean F. Rigel, Ichiro Umemura, (unknown), Guoming Zhu, Muneto Mogi	8
6	Systematic Evaluation of Wajima Superposition (Steady-State Concentration to Mean Residence Time) in the Estimation of Human Intravenous Pharmacokinetic Profile 2016 ·Journal of Pharmaceutical Sciences ·Franco Lombardo, Giuliano Berellini, Laura R. LaBonte, Guiqing Liang, (unknown)	6
7	Compound Property Optimization in Drug Discovery Using Quantitative Surface Sampling Micro Liquid Chromatography with Tandem Mass Spectrometry 2016 ·Analytical Chemistry ·Xiaohong Chen, Panos Hatsis, (unknown), Upendra A. Argikar, Xiaojun Ren, (unknown), Keith G. Mansfield, Guiqing Liang, Adam Amaral, (unknown), Adam J. Bentley, (unknown), Paul Moench, Samuel Hintermann, David A. Carcache, (unknown), Jimmy Flarakos	10
8	Discovery of N-[5-(6-Chloro-3-cyano-1-methyl-1H-indol-2-yl)-pyridin-3-ylmethyl]-ethanesulfonamide, a Cortisol-Sparing CYP11B2 Inhibitor that Lowers Aldosterone in Human Subjects 2015 ·Journal of Medicinal Chemistry ·Julien P. N. Papillon, (unknown), Alok Kumar Singh, Christopher M. Adams, Gary M. Ksander, Michael E. Beil, Wei Chen, (unknown), Fumin Fu, Lu Gan, (unknown), Arco Y. Jeng, Daniel LaSala, Guiqing Liang, Dean F. Rigel, Kerry S. Russell, Joshua R. Vest, Catherine E. Watson	23
9	Aldosterone synthase inhibition: cardiorenal protection in animal disease models and translation of hormonal effects to human subjects 2014 ·Journal of Translational Medicine ·Joël Ménard, Dean F. Rigel, Catherine E. Watson, Arco Y. Jeng, Fumin Fu, Michael E. Beil, Jing Liu, Wei Chen, (unknown), (unknown), Daniel LaSala, Guiqing Liang, Sam Rebello, Yiming Zhang, William P. Dole	47
10	Identification of saturated and unsaturated fatty acids released during microsomal incubations 2014 ·Xenobiotica ·(unknown), Guiqing Liang, Christine E. Dunne, Shawn Harriman, Upendra A. Argikar	8
11	Discovery of 2-Pyridylpyrimidines as the First Orally Bioavailable GPR39 Agonists 2014 ·ACS Medicinal Chemistry Letters ·Stefan Peukert, Richard L. Hughes, Jill Nunez, Guo‐Wei He, (unknown), Rishi K. Jain, Luis Llamas, Sarah J. Luchansky, Adam Carlson, Guiqing Liang, Vidya Kunjathoor, (unknown), Jeffrey Shapiro, (unknown), Xiaoping Wu, Avirup Bose	34
12	Syntheses and antitumor activities of N′1,N′3-dialkyl-N′1,N′3-di-(alkylcarbonothioyl) malonohydrazide: The discovery of elesclomol 2013 ·Bioorganic & Medicinal Chemistry Letters ·Shoujun Chen, Lijun Sun, Keizo Koya, Noriaki Tatsuta, Zhiqiang Xia, Timothy Korbut, Zhenjian Du, Jim Zhen Wu, Guiqing Liang, Jun Jiang, Mitsunori Ono, Dan Zhou, Andrew J. Sonderfan	43
13	Evaluation of Pharmaceutical Excipients as Cosolvents in 4-Methyl Umbelliferone Glucuronidation in Human Liver Microsomes: Applications for Compounds with Low Solubility 2010 ·Drug Metabolism and Pharmacokinetics ·Upendra A. Argikar, Guiqing Liang, (unknown), Vinayak Hosagrahara, Wendy Lee	10
14	The discovery of potent inhibitors of aldosterone synthase that exhibit selectivity over 11-β-hydroxylase 2010 ·Bioorganic & Medicinal Chemistry Letters ·Christopher M. Adams, (unknown), Arco Y. Jeng, Rajeshri G. Karki, Gary M. Ksander, (unknown), (unknown), Guiqing Liang, Qian Liu, Erik L. Meredith, (unknown), Dean F. Rigel, Jie Shi, Sherri Smith, Clayton Springer, Chun Zhang	10
15	Pharmacodynamic and Pharmacokinetic Characterization of the Aldosterone Synthase Inhibitor FAD286 in Two Rodent Models of Hyperaldosteronism: Comparison with the 11β-Hydroxylase Inhibitor Metyrapone 2010 ·Journal of Pharmacology and Experimental Therapeutics ·Dean F. Rigel, Fumin Fu, Michael E. Beil, (unknown), Guiqing Liang, Arco Y. Jeng	46
16	Indole- and indolizine-glyoxylamides displaying cytotoxicity against multidrug resistant cancer cell lines 2008 ·Bioorganic & Medicinal Chemistry Letters ·David A. James, Keizo Koya, Hao Li, Guiqing Liang, Zhiqiang Xia, Weiwen Ying, Yaming Wu, Lijun Sun	89
17	The aldosterone synthase inhibitor FAD286 reduces plasma aldosterone concentration (PAC) with a long duration of action in a rat model of subchronic hyperaldosteronism 2008 ·The FASEB Journal ·Wei Chen, Fumin Fu, Michael E. Beil, Jing Liu, (unknown), Guiqing Liang, Wieslawa Maniara, Arco Y. Jeng, Dean F. Rigel	1
18	Effects of the guanine-quadruplex telomerase inhibitor BRACO-19 on tumour cells: Evidence of selective action on telomere maintenance 2004 ·Cancer Research ·Keizo Koya, Lijun Sun, Shoujun Chen, Noriaki Tatsuta, Timothy Korbut, Dan Zhou, Guiqing Liang, Yaming Wu, Zhenjian Du, Zhiqiang Xia, Thomas Dahl, James Barsoum, Mitsunori Ono, Lan Bo Chen	1
19	Searching for the Lowest Energy Conformation of Substrates in the Carboxypeptidase A Active Site Using Monte Carlo/Energy Minimization Techniques 1998 ·Bioorganic Chemistry ·Guiqing Liang, John F. Sebastian	1
20	Effect of Enzyme–Substrate Interactions Away from the Reaction Site on Carboxypeptidase A Catalysis 1996 ·Bioorganic Chemistry ·John F. Sebastian, Guiqing Liang, (unknown), Karen Thomas, (unknown)	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact